Circulating levels of high molecular weight (HMW) adiponectin and total adiponectin in relation to fat distribution, oxidative stress and inflammation in Asian Indians

Disease Markers

Volumn 33, Issue 4, 2012, Pages 185-192

  Indulekha, K ^a   Surendar, J ^a   Anjana, R M ^a   Gokulakrishnan, K ^a   Balasubramanyam, M ^a   Aravindhan, V ^b   Mohan, V ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b ANNA UNIVERSITY   (India)

Author keywords

adipocytokines; Asian Indians; Metabolic syndrome; obesity; type 2 diabetes

Indexed keywords

2,4 DINITROPHENYLHYDRAZINE; ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARBONYL DERIVATIVE; CHOLESTEROL; CREATININE; HIGH MOLECULAR WEIGHT ADIPONECTIN; HIGH SENSITIVITY C REACTIVE PROTEIN; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INDIAN; INFLAMMATION; INTRAABDOMINAL FAT; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; SMOKING; SUBCUTANEOUS FAT;

EID: 84872226810     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2012-0924     Document Type: Article

References (28)

1. Han SH, Sakuma I, Shin EK, Koh KK. Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies. Prog Cardiovasc Dis. 2009 Sep-Oct; 52(2): 126-40.
2. Verkest KR, Rand JS, Fleeman LM,Morton JM, Richards AA, Rose FJ, Whitehead JP. Distinct adiponectin profiles might contribute to differences in susceptibility to type 2 diabetes in dogs and humans. Domest Anim Endocrinol. 2011 Aug; 41(2): 67-73.
3. Kishida K, Kim KK, Funahashi T, Matsuzawa Y, Kang HC, Shimomura I. Relationships between circulating adiponectin levels and fat distribution in obese subjects. J Atheroscler Thromb. 2011 Jul 22; 18(7): 592-5.
4. Kaser S, Tatarczyk T, Stadlmayr A, Ciardi C, Ress C, Tschoner A, Sandhofer A, Paulweber B, Ebenbichler CF, Patsch JR. Effect of obesity and insulin sensitivity on adiponectin isoform distribution. Eur J Clin Invest. 2008 Nov; 38(11): 827-34.
5. Baumann M, von Eynatten M, Dan L, Richart T, Kouznetsova T, Heemann U, Staessen JA. Altered molecular weight forms of adiponectin in hypertension. J Clin Hypertens (Greenwich). 2009 Jan; 11(1): 11-6.
6. Magkos F,Mohammed BS, Mittendorfer B. Enhanced insulin sensitivity after acute exercise is not associated with changes in high-molecularweight adiponectin concentration in plasma. Eur J Endocrinol. 2010 Jan; 162(1): 61-6.
7. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA, Scherer PE. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem. 2004 Mar 26; 279(13): 12152-62.
8. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol. 2004 May; 24(5): 816-23.
9. Findeisen HM, Pearson KJ, Gizard F, Zhao Y, Qing H, Jones KL, Cohn D, Heywood EB, de Cabo R, Bruemmer D. Oxidative stress accumulates in adipose tissue during aging and inhibits adipogenesis. PLoS One. 2011 Apr 14; 6(4): e18532.
10. Indulekha K, AnjanaRM, Surendar J,MohanV.Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113). Clin Biochem. 2011 Mar; 44(4): 281-7.
11. Briggs DB, Giron RM, Malinowski PR, Nuñez M, Tsao TS. Role of redox environment on the oligomerization of higher molecular weight adiponectin. BMC Biochem. 2011 May 23; 12(1): 24.
12. DeepaM, Pradeepa R, RemaM, et al. The Chennai Urban Rural Epidemiology Study (CURES)-study design and methodology (urban component) (CURES-1). J Assoc Physicians India 2003; 51: 863-70.
13. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976; 15: 212-6.
14. Levin RL, Garlan D, Oliver CN, Amici A, Clement I, Lenz AG.Determination of carbonyl content in oxidativelymodified proteins. Methods Enzymol 1990; 186: 464-78.
15. Lonn E, Yusuf S, Dzavik V, Doris C, Yi Q, Smith S, Moore-Cox A, Bosch J, Riley W, Teo K. SECURE Investigators: Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 2001; 103: 919-925.
16. Neumeier M, Weigert J, Scḧaffler A, Wehrwein G, M̈uller-Ladner U, Scḧolmerich J, Wrede C, Buechler C. Different effects of adiponectin isoforms in human monocytic cells. J Leukoc Biol. 2006 Apr; 79(4): 803-8.
17. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991 Apr; 40(4): 405-12.
18. Carru C, Pasciu V, Sotgia S, Zinellu A, Nicoli MC, Deiana L, Tadolini B, Sanna B, Masala B, Pintus G. The Oxidative State of LDL is the Major Determinant of Anti/Prooxidant Effect of Coffee on Cu Catalysed Peroxidation. Open Biochem J. 2011; 5: 1-8.
19. Zhou M, Xu A, Tam PK, Lam KS, Chan L, Hoo RL, Liu J, Chow KH,Wang Y. Mitochondrial dysfunction contributes to the increased vulnerabilities of adiponectin knockout mice to liver injury. Hepatology. 2008 ct; 48(4): 1087-96.
20. Goldstein BJ, Scalia RG, Ma XL. Protective vascular and myocardial effects of adiponectin. Nat Clin Pract Cardiovasc Med. 2009 Jan; 6(1): 27-35.
21. Adachi M, Brenner DA. High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase. Hepatology. 2008 Feb; 47(2): 677-85.
22. Sam S,Haffner S, Davidson MH,D'Agostino RB Sr, Feinstein S, Kondos G, Perez A, Mazzone T. Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes. Diabetes Care. 2009 May; 32(5): 932-7.
23. Ohashi N, Ito C, Fujikawa R, Yamamoto H, Kihara Y, Kohno N. The impact of visceral adipose tissue and high-molecular weight adiponectin on cardio-ankle vascular index in asymptomatic Japanese subjects.Metabolism. 2009 Jul; 58(7): 1023-9.
24. Ferńandez-Veledo S, Vila-Bedmar R, Nieto-Vazquez I, Lorenzo M. c-Jun N-terminal kinase 1/2 activation by tumor necrosis factor-alpha induces insulin resistance in human visceral but not subcutaneous adipocytes: reversal by liver X receptor agonists. J Clin Endocrinol Metab. 2009; s94(9): 3583-93.
25. Hajri T, TaoH,Wattacheril J,Marks-Shulman P,AbumradNN. Regulation of adiponectin production by insulin: interactions with tumor necrosis factor-α and interleukin-6. Am J Physiol Endocrinol Metab. 2011 Feb; 300(2): E350-60.
26. Tabara Y, Osawa H, Kawamoto R, Tachibana-Iimori R, Yamamoto M, sNakura J, Miki T, Makino H, Kohara K. Reduced high-molecular-weight adiponectin and elevated highsensitivity C-reactive protein are synergistic risk factors for metabolic syndrome in a large-scale middle-aged to elderly population: the Shimanami Health Promoting Program Study. J Clin Endocrinol Metab. 2008 Mar; 93(3): 715-22.
27. Festa A, D'Agostino R Jr, Howard G, Mykk̈anen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000; 102(1): 42-7.
28. Xu A, Chan KW, Hoo RL,Wang Y, Tan KC, Zhang J, Chen B, LamMC, Tse C, Cooper GJ, LamKS. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem. 2005 May 6; 280(18): 18073-80.